LivaNova PLC Ordinary Shares (LIVN)

About LIVN

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as servi…

Sector

Health Care

Industry

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Employees

3,300

Website

www.livanova.com/

Fundamentals

1-day range

$79.43$80.77

Market cap

$4.16B

P/E (trailing)

23.84

P/E (forward)

17.17

EPS (trailing)

$3.38

Dividend yield

—

Beta

0.87

Avg. volume

709.3K

Forecasts

10 analyst ratings

LivaNova PLC Ordinary Shares Competitors

Chosen by industry and closest market cap.

• LIVN

  LivaNova PLC Ordinary Shares

  $80.34

  ▲ 0.39%
  Market cap $4.16BP/E 23.84
  $48.82$85.76
• TMDX

  TransMedics Group Inc. Common Stock

  $88.48

  ▼ 3.57%
  Market cap $2.78BP/E —
• BLFS

  BioLife Solutions Inc. Common Stock

  $36.4

  ▼ 2.15%
  Market cap $1.66BP/E 29.72
  $17.86$38.1
• CNMD

  CONMED Corporation Common Stock

  $49.98

  ▼ 0.68%
  Market cap $1.49BP/E 26.36
  $31.44$56.64
• ELMD

  Electromed Inc. Common Stock

  $29.65

  ▼ 1.63%
  Market cap $348.09MP/E 34.86
  $23.01$47.4
• CV

  CapsoVision Inc. Common Stock

  $5.95

  ▼ 1.82%
  Market cap $344.75MP/E —
  $3.43$15.37
• FOCL

  EDAP TMS S.A. American Depositary Shares

  $4.3

  ▼ 0.92%
  Market cap $228.65MP/E —
  $4.01$6.4

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• LivaNova: Careful About The Valuation And Upside
  SeekingAlpha · 8/25/2026
• Artisan International Small-Mid Fund Q2 2026 Portfolio Review
  SeekingAlpha · 8/24/2026
• LivaNova (NASDAQ:LIVN) Combines Strong Growth With a Promising Technical Breakout Setup
  ChartMill · 8/18/2026
• NeuroPace Faces an IGE Delay: What the FDA Setback Means for Growth
  Yahoo · 8/17/2026
• Is NeuroPace a Buy as Growth Improves but Valuation Stays Elevated?
  Yahoo · 8/17/2026
• Ahmet Tezel Executes Sell Order: Offloads $876K In LivaNova Stock
  Benzinga · 8/14/2026
• Stronger Q2 Results And New Supply Deal Might Change The Case For Investing In LivaNova (LIVN)
  Yahoo · 8/12/2026
• LivaNova (LIVN) Could Be 5% Undervalued Following Raised 2026 Guidance
  Yahoo · 8/12/2026

• Tezel Ahmet · August 11, 2026 · Option Exercise

  12.7K @ $52.68
• Tezel Ahmet · August 11, 2026 · Sale

  2.7K @ $77.74
• Tezel Ahmet · August 11, 2026 · Tax Withholding

  1.4K @ $77.86
• Tezel Ahmet · August 11, 2026 · Disposition

  8.6K @ $77.86
• Bianchi Francesco · June 15, 2026 · Grant

  2.4K
• Bianchi Francesco · June 15, 2026 · Option Exercise

  4.0K
• Bianchi Francesco · June 15, 2026 · Sale

  1.2K @ $80.19
• Bianchi Francesco · June 15, 2026 · Tax Withholding

  486 @ $79.7
• PODLOGAR SUSAN M · June 15, 2026 · Grant

  2.4K
• PODLOGAR SUSAN M · June 15, 2026 · Option Exercise

  4.0K
• PODLOGAR SUSAN M · June 15, 2026 · Tax Withholding

  486 @ $79.7
• Barry James Christopher · June 15, 2026 · Grant

  2.4K
• Barry James Christopher · June 15, 2026 · Option Exercise

  4.0K
• Barry James Christopher · June 15, 2026 · Tax Withholding

  486 @ $79.7
• Tezel Ahmet · June 15, 2026 · Option Exercise

  3.0K